메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한골다공증학회 OSTEOPOROSIS OSTEOPOROSIS 제7권 제1호
발행연도
2009.1
수록면
28 - 34 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objectives: To determine the effect of tibolone add- back therapy for prevention of bone mineral density loss in women treated with GnRH agonist for their endometriosis. Methods: Medical records of 179patients who had been given a laparoscopically or pathologically proven diagnosis of endometriosis and finished the 6cycles of goserelin acetate 3.78mg treatment were reviewed retrospectively. Twenty five patients were excluded because either or both pre-and post-treatment bone mineral density(BDM) examination was not carried out. The BMD of the lumbar spine(L1-L4) and femur neck was measured by dual energy X-ray absorptiometry two times(Pre- and post-GnRH agonist treatment). Tibolone add-back therapy was given to 97patients and remaining 57patients were not received. Results: The mean age was 40.61±6.89years and mean body mass index was 23.43±3.14(kg/㎠). Comparing to pretreatment value, the mean decrease of BMD of lumbar spine and femur neck in without add-back group and with add-back group was 0.060±0.024 and 0.047±0.022, respectively. The mean decrease of BMD of lumbar spine was prevented significantly in add-back group(P=0.044). Conclusions: Tibolone add-back therapy could prevent BMD loss occurs during 6 cycles of GnRH agonist treatment especially in lumbar spine.

목차

등록된 정보가 없습니다.

참고문헌 (24)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0